Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
MTHFR, MS variants in folate metabolic pathway linked to reduced CIN 2/3 risk
March 31st, 2005
Study data indicate that polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes are associated with reduced risk of cervical intraepithelial neoplasia 2 or 3 in women with adequate folic acid intake. According to University of Alabama, Birmingham, nutrition scientists, "The role of nutrient-related genetic susceptibility factors for precancerous lesions is gaining attention." They "conducted a study to examine associations between polymorphisms in folate pathway coenzymes (methylenetetrahydrofolate reductase [MTHFR] and methionine synthase [MS]) and cervical intraepithelial neoplasia (CIN) 2 or 3 in a population exposed to...
Source: Women's Health Weekly (2005-03-31)
|
